Related references
Note: Only part of the references are listed.Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells
Songjiang Wu et al.
ONCOTARGETS AND THERAPY (2018)
Fueling the Cell Division Cycle
Maria Salazar-Roa et al.
TRENDS IN CELL BIOLOGY (2017)
Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells
Zheng-Hai Tang et al.
REDOX BIOLOGY (2017)
Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells
Miao He et al.
PLOS ONE (2017)
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Wanjun Lin et al.
SCIENTIFIC REPORTS (2017)
Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer
Xi Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model
Jingwen Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
Rosania Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency
Weili Zheng et al.
SCIENTIFIC REPORTS (2015)
Protective Effects of Chelerythrine Against Lipopolysaccharide-Induced Endotoxic Shock in Mice
Xiaofeng Niu et al.
INFLAMMATION (2014)
Targeting apoptosis pathways in cancer by Chinese medicine
Min Li-Weber
CANCER LETTERS (2013)
Interleukin-6 signaling pathway in targeted therapy for cancer
Yuqi Guo et al.
CANCER TREATMENT REVIEWS (2012)
In Vitro Antifungal Activity of Sanguinarine and Chelerythrine Derivatives against Phytopathogenic Fungi
Xin-Juan Yang et al.
MOLECULES (2012)
Induction of Apoptosis by Chelerythrine Chloride through Mitochondrial Pathway and Bcl-2 Family Proteins in Human Hepatoma SMMC-7721 Cell
Zheng-fu Zhang et al.
ARCHIVES OF PHARMACAL RESEARCH (2011)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Kiran Gupta et al.
CANCER TREATMENT REVIEWS (2008)
Chelerythrine and dihydrochelerythrine induce G1 phase arrest and bimodal cell death in human leukemia HL-60 cells
Jiri Vrba et al.
TOXICOLOGY IN VITRO (2008)
Plant natural products: Back to the future or into extinction?
James D. McChesney et al.
PHYTOCHEMISTRY (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The signaling mechanism of ROS in tumor progression
Wen-Sheng Wu
CANCER AND METASTASIS REVIEWS (2006)
The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine
J. Malikova et al.
CELL BIOLOGY AND TOXICOLOGY (2006)
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer
EB Haura et al.
CLINICAL CANCER RESEARCH (2005)
Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells
J Boonstra et al.
GENE (2004)
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
NK Janzen et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity
KR Martin et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Share Paper
